VALBIOTIS’ Research & Development activities focus on preventing and combating metabolic and cardiovascular diseases.
Their purpose: develop a new class of products designed to reduce the risk factors for major metabolic diseases such as type 2 diabetes and NASH or cardiovascular diseases.
VALBIOTIS has adopted an innovative strategy in order to prevent metabolic and cardiovascular diseases: to develop products that can simultaneously act on different physiological targets of interest.
Rigorous development plans are implemented for all VALBIOTIS products, founded on the same principles as drug development plans.Learn more
To develop its products, VALBIOTIS has constructed a proprietary tool: VALBIOTIS R&D, an integrated Research and Development platform, specifically designed for researching plants and their applications in the field of metabolic and cardiovascular diseases.
This cross-disciplinary entity brings together expert teams and infrastructures focused on plant-based chemistry, preclinical research on the metabolism and clinical development.Learn more
VALBIOTIS is guided by a Scientific and Medical advisory board composed of internationally renowned experts in physiology, endocrinology, diabetology, clinical development and innovative formulation.Learn more